Cita APA

Leder, B. Z., Zapalowski, C., Hu, M., Hattersley, G., Lane, N. E., Singer, A. J., & Dore, R. K. (2019). Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial. J Bone Miner Res.

Chicago Style Citation

Leder, Benjamin Z., Carol Zapalowski, Ming‐Yi Hu, Gary Hattersley, Nancy E. Lane, Andrea J. Singer, i Robin K. Dore. "Fracture and Bone Mineral Density Response By Baseline Risk in Patients Treated With Abaloparatide Followed By Alendronate: Results From the Phase 3 ACTIVExtend Trial." J Bone Miner Res 2019.

Cita MLA

Leder, Benjamin Z., et al. "Fracture and Bone Mineral Density Response By Baseline Risk in Patients Treated With Abaloparatide Followed By Alendronate: Results From the Phase 3 ACTIVExtend Trial." J Bone Miner Res 2019.